Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000906304-26-000004·Apyx Medical Corp
Schedule 13G ownership disclosure
APYX MEDICAL CORPORATION
Common Stock · CUSIP: 03837C106
Event date: 2025-12-31
- Filing-level shares
- 2,443,035.00
- Percent of class
- 5.95%
- ROYCE & ASSOCIATES LP
Shares: 2,443,035.00 · Class: 5.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000906304-26-000004
- Form type
- SCHEDULE 13G/A
- Filer
- Apyx Medical Corp
- CIK
- CIK 719135
- Filed
- Jan 20, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership